Eija Korkeila
-
- Cancer, Hypoxia, and Metabolism 5
- Oncology top 10%
- Colorectal Cancer Treatments and Studies 7
- Colorectal Cancer Surgical Treatments 6
- Cancer Cells and Metastasis 4
- Pancreatic and Hepatic Oncology Research 4
- Pathology and Forensic Medicine top 10%
- Genetic factors in colorectal cancer 10
-
- Neurofibromatosis and Schwannoma Cases 4
-
- Renal cell carcinoma treatment 3
In The Last Decade
Eija Korkeila
29 papers receiving 538 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 148
- Oncology 253
- Pathology and Forensic Medicine 135
- Neurology 76
- Immunology and Allergy 26
Countries citing papers authored by Eija Korkeila
This map shows the geographic impact of Eija Korkeila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eija Korkeila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eija Korkeila more than expected).
Fields of papers citing papers by Eija Korkeila
This network shows the impact of papers produced by Eija Korkeila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eija Korkeila. The network helps show where Eija Korkeila may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eija Korkeila, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 5 | |
| 2 | 2019 | 14 | |
| 3 | 2019 | 30 | |
| 4 | 2017 | 13 | |
| 5 | 2017 | 5 | |
| 6 | 2013 | 24 | |
| 7 | Main effects and interactions of carbonic anhydrase IX, hypoxia-inducible factor-1α, ezrin and glucose transporter-1 in multivariate analysis for disease outcome in rectal cancer. | 2012 | 5 |
| 8 | Pronounced tumour regression after radiotherapy is associated with negative/weak glucose transporter-1 expression in rectal cancer. | 2011 | 14 |
| 9 | 2011 | 4 | |
| 10 | 2010 | 15 | |
| 11 | 2010 | 14 | |
| 12 | 2009 | 12 | |
| 13 | 2009 | 96 | |
| 14 | 2009 | 1 | |
| 15 | 2008 | 81 | |
| 16 | 2008 | 13 | |
| 17 | 2008 | 53 | |
| 18 | 2008 | 4 | |
| 19 | 2007 | 20 | |
| 20 | 2006 | 7 |
About Eija Korkeila
Eija Korkeila is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research, having authored 29 papers that have together received 551 indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (10 papers), Colorectal Cancer Treatments and Studies (7 papers), Colorectal Cancer Surgical Treatments (6 papers), Cancer, Hypoxia, and Metabolism (5 papers), Cancer Cells and Metastasis (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Neurofibromatosis and Schwannoma Cases (4 papers) and Renal cell carcinoma treatment (3 papers). The work is most often cited by research in Cancer Research (148 citations), Oncology (253 citations) and Pathology and Forensic Medicine (135 citations). Eija Korkeila has collaborated with scholars based in Finland, Libya and Brazil. Frequent co-authors include Karí Syrjänen, Seppo Pyrhönen, Jari Sundström, Olli Carpén, Adam Elzagheid, Riyad Bendardaf, Panu Jaakkola, Abdelbaset Buhmeida, Heikki Minn and Yrjö Collan. Their work appears in journals such as Human Pathology, Acta Oncologica, British Journal of Cancer, Cancer Medicine and World Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.